Intimation of Closure of Trading Window pursuant to declaration of Audited Financial Results for the Quarter and Year ended March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venmax Drugs and Pharmaceuticals has informed the BSE that the trading window for dealing in its securities will be closed for all insiders, designated persons, and their immediate relatives starting April 1, 2026. The window will remain shut until 48 hours after the company declares its audited financial results for the quarter and financial year ended March 31, 2026. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015. The exact date of the board meeting to approve these results will be communicated separately.
This is a routine regulatory filing and not a material business event. No direct impact on shareholders or stock price is expected. Investors should note that insider trades (if any) will be restricted during this blackout period, and the upcoming audited results will be the next key catalyst for the stock.